PEAK6 Group’s NxStage Medical Inc. NXTM Stock Holding History

PEAK6 Group’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.67M	Sell	60,000 -15,000	-20%	-$402K	0.01%	1509
2018 Q1	$1.86M	Buy	75,000 +20,000	+36%	+$486K	0.01%	1445
2017 Q4	$1.33M	Sell	55,000 -12,652	-19%	-$333K	0.01%	1707
2017 Q3	$1.87M	Buy	+67,652	New	+$1.8M	0.01%	1451
2017 Q2	–	Sell	-7,976	Closed	-$214K	–	5321
2017 Q1	$214K	Buy	+7,976	New	+$220K	﹤0.01%	3026
2016 Q1	–	Sell	-12,149	Closed	-$266K	–	5358
2015 Q4	$266K	Sell	12,149 -68,015	-85%	-$1.27M	﹤0.01%	3185
2015 Q3	$1.26M	Sell	80,164 -15,637	-16%	-$251K	0.01%	1967
2015 Q2	$1.37M	Buy	95,801 +74,145	+342%	+$1.26M	0.01%	1801
2015 Q1	$375K	Buy	+21,656	New	+$383K	﹤0.01%	2847
2014 Q3	–	Sell	-12,300	Closed	-$177K	–	5419
2014 Q2	$177K	Buy	+12,300	New	+$161K	﹤0.01%	3328
2013 Q3	–	Sell	-8,400	Closed	-$120	–	5696
2013 Q2	$120	Buy	+8,400	New	+$106K	﹤0.01%	4008

Other funds holding NXTM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

PEAK6 Group's NXTM Position: Q2 2018 in Review

PEAK6 Group reduced its NxStage Medical Inc. (NXTM) stake by 20% in Q2 2018, selling an estimated $402K and leaving 60,000 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #1509.

PEAK6 Group first reported a position in NXTM in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.87M in Q3 2017. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

PEAK6 Group held 60,000 shares of NxStage Medical Inc. worth $1.67M as of Q2 2018.
PEAK6 Group sold 15,000 NxStage Medical Inc. shares in Q2 2018, an estimated $402K.
NxStage Medical Inc. made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1509 holding.
PEAK6 Group first reported a position in NxStage Medical Inc. in Q2 2013 and has held it in 11 quarters since.
PEAK6 Group's NxStage Medical Inc. position peaked at $1.87M in Q3 2017.
171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.